Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study

Kidney transplant recipients (KTR) are considered high-risk for morbidity and mortality from coronavirus disease 2019 (COVID-19). However, some studies did not show worse outcomes compared to non-transplant patients and there is little data about immunosuppressant drug levels and secondary infection...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2021-05, Vol.53 (4), p.1187-1193
Hauptverfasser:	Hardesty, Anna, Pandita, Aakriti, Vieira, Kendra, Rogers, Ralph, Merhi, Basma, Osband, Adena J., Aridi, Jad, Shi, Yiyun, Bayliss, George, Cosgrove, Christopher, Gohh, Reginald, Morrissey, Paul, Beckwith, Curt G., Farmakiotis, Dimitrios
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral Agents - therapeutic use Case-Control Studies COVID-19 - complications COVID-19 - diagnosis COVID-19 - virology COVID-19 Drug Treatment Female Graft Rejection - prevention & control Humans Immunology Immunosuppressive Agents - therapeutic use Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Kidney Transplantation Length of Stay Life Sciences & Biomedicine Male Middle Aged Pandemics SARS-CoV-2 - isolation & purification Science & Technology Sirolimus - therapeutic use Surgery Tacrolimus - therapeutic use The Second COVID-19 Minisymposium TOR Serine-Threonine Kinases - metabolism Transplantation Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!